Johnson & Johnson (JNJ)
146.62
-1.91
(-1.29%)
USD |
NYSE |
Apr 25, 11:08
Johnson & Johnson Cash and Short Term Investments (Quarterly): 22.93B for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 22.93B |
September 30, 2023 | 23.51B |
June 30, 2023 | 28.50B |
March 31, 2023 | 24.61B |
December 31, 2022 | 22.28B |
September 30, 2022 | 34.08B |
June 30, 2022 | 32.57B |
March 31, 2022 | 30.39B |
December 31, 2021 | 31.61B |
September 30, 2021 | 31.00B |
June 30, 2021 | 25.31B |
March 31, 2021 | 24.62B |
December 31, 2020 | 25.18B |
September 30, 2020 | 30.78B |
June 30, 2020 | 19.14B |
March 31, 2020 | 18.02B |
December 31, 2019 | 19.29B |
September 30, 2019 | 17.94B |
June 30, 2019 | 15.28B |
March 31, 2019 | 15.34B |
December 31, 2018 | 19.69B |
September 30, 2018 | 19.36B |
June 30, 2018 | 18.14B |
March 31, 2018 | 15.20B |
December 31, 2017 | 18.30B |
Date | Value |
---|---|
September 30, 2017 | 16.23B |
June 30, 2017 | 12.85B |
March 31, 2017 | 39.34B |
December 31, 2016 | 41.91B |
September 30, 2016 | 40.43B |
June 30, 2016 | 42.58B |
March 31, 2016 | 39.86B |
December 31, 2015 | 38.38B |
September 30, 2015 | 37.31B |
June 30, 2015 | 33.95B |
March 31, 2015 | 31.32B |
December 31, 2014 | 33.09B |
September 30, 2014 | 33.00B |
June 30, 2014 | 31.62B |
March 31, 2014 | 29.39B |
December 31, 2013 | 29.21B |
September 30, 2013 | 25.23B |
June 30, 2013 | 25.13B |
March 31, 2013 | 21.67B |
December 31, 2012 | 21.09B |
September 30, 2012 | 19.77B |
June 30, 2012 | 16.92B |
March 31, 2012 | 33.85B |
December 31, 2011 | 32.26B |
September 30, 2011 | 30.93B |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
15.28B
Minimum
Jun 2019
34.08B
Maximum
Sep 2022
25.11B
Average
24.62B
Median
Mar 2021
Cash and Short Term Investments (Quarterly) Benchmarks
Amgen Inc | 10.94B |
Gilead Sciences Inc | 7.264B |
Eli Lilly and Co | 2.928B |
Merck & Co Inc | 7.093B |
Shockwave Medical Inc | 990.55M |